Loss of phospho-tyrosine-dependent ShcA signaling (Y239/240/313F) increased the reliance of breast cancer cells on mitochondrial metabolism, exposing a selective vulnerability to phenformin28. The gene discussed is SHC1; the disease is breast carcinoma.